US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

210.60

+1.100.53%

Pre-market: 210.600.00000.00%07:19 EDT

Volume:5.52M

Turnover:1.16B

Market Cap:372.04B

PE:100.28

High:211.47

Open:210.84

Low:207.12

Close:209.50

52wk High:218.66

52wk Low:163.81

Shares:1.77B

Float Shares:1.76B

Volume Ratio:1.08

T/O Rate:0.31%

Dividend:6.47

Dividend Rate:3.07%

EPS(TTM):2.10

EPS(LYR):2.40

ROE:112.85%

ROA:8.87%

PB:-2032.99

PE(LYR):87.91

Loading ...

Overview Company News Filings

AbbVie’s IMGN151 Study: A New Hope for Recurrent Gynecological Cancers

AbbVie’s Promising CLL Study: A Potential Game-Changer for Investors

AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa

AbbVie’s Promising Rheumatoid Arthritis Study: A Potential Game-Changer?

AbbVie’s Promising Study on Targeted Therapies for Crohn’s Disease

AbbVie’s SUNRISE-UC Study: A Real-World Evaluation of Risankizumab for Ulcerative Colitis

Raymond James Sticks to Their Buy Rating for AbbVie (ABBV)

AbbVie (ABBV.US) Rinvoq Alopecia Areata Therapy Meets Primary Endpoints in Late-Stage Trials, Plans Regulatory Submissions

AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study

Simply Wall St.

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

AbbVie's Rinvoq Hits Key Endpoints in 2nd Alopecia Areata Phase 3 Study

AbbVie’s upadacitinib achieves endpoint in Phase 3 alopecia areata trial

AbbVie Announces Positive Results from Phase 3 Trial of Upadacitinib for Alopecia Areata, Showing Promising Hair Regrowth Outcomes

Abbvie Inc - Upadacitinib Achieves Primary Endpoint in Alopecia Areata Trial

THOMSON REUTERS

Abbvie Inc - Key Secondary Endpoints Met in Upadacitinib Trial

THOMSON REUTERS

Abbvie Inc - Upadacitinib Safety Profile Consistent With Approved Indications

THOMSON REUTERS

Abbvie Announces Positive Topline Results From Second Phase 3 up-Aa Trial Evaluating Upadacitinib (Rinvoq®) for Alopecia Areata

THOMSON REUTERS

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

AbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Relief

AbbVie’s Promising Crohn’s Disease Study: A Potential Game Changer?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABBV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABBV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"AbbVie","latestPrice":210.6,"timestamp":1755892800000,"preClose":209.5,"halted":0,"volume":5516772,"hourTrading":{"tag":"盘前","latestPrice":210.6,"preClose":210.6,"latestTime":"07:19 EDT","volume":59,"amount":12401.349830000001,"timestamp":1756120799909},"delay":0,"floatShares":1762950764,"shares":1766558253,"eps":2.100163,"marketStatus":"Pre-Mkt","change":1.1,"latestTime":"08-25 07:24:12 EDT","open":210.84,"high":211.47,"low":207.12,"amount":1158132084.2196,"amplitude":0.020764,"askPrice":210.69,"askSize":57,"bidPrice":210.29,"bidSize":50,"shortable":3,"etf":0,"ttmEps":2.100163,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756128600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":210.6,"dividendRate":0.030722,"preHourTrading":{"tag":"盘前","latestPrice":210.6,"preClose":210.6,"latestTime":"07:19 EDT","volume":59,"amount":12401.349830000001,"timestamp":1756120799909},"postHourTrading":{"tag":"盘后","latestPrice":210.28,"preClose":210.6,"latestTime":"19:59 EDT","volume":1472726,"amount":310155404.5097,"timestamp":1755907168853},"volumeRatio":1.077611006778599,"impliedVol":0.2129,"impliedVolPercentile":0.0402},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","floatShares":1762950764,"roa":"8.87%","roe":"112.85%","lyrEps":2.395703,"volumeRatio":1.077611006778599,"shares":1766558253,"dividePrice":6.47,"high":211.47,"amplitude":0.020764,"preClose":209.5,"low":207.12,"week52Low":163.81,"pbRate":"-2032.99","psRate":"6.38","week52High":218.66,"institutionHeld":0,"latestPrice":210.6,"committee":-0.065421,"eps":2.100163,"divideRate":0.030722,"volume":5516772,"delay":0,"ttmEps":2.100163,"open":210.84,"prevYearClose":177.7,"prevWeekClose":210.6,"prevMonthClose":189.02,"prevQuarterClose":185.62,"fiveDayClose":206.69,"twentyDayClose":190.28,"sixtyDayClose":183.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABBV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-31","symbol":"ABBV","fiscalQuarterEnding":"2025/06","expectedEps":2.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":2.97},{"date":"2025-07-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-15","defaultRemindTime":1752586200000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-07-15","currency":"USD","dateTimestamp":1752552000000,"payDate":"2025-08-15"},{"market":"US","date":"2025-04-25","symbol":"ABBV","fiscalQuarterEnding":"2025/03","expectedEps":2.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745553600000,"reportTimeType":"pre","actualEps":2.46},{"date":"2025-04-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-15","defaultRemindTime":1744723800000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-15","currency":"USD","dateTimestamp":1744689600000,"payDate":"2025-05-15"},{"market":"US","date":"2025-01-31","symbol":"ABBV","fiscalQuarterEnding":"2024/12","expectedEps":2.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":2.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABBV\",market:\"US\",,,undefined,":[{"executeDate":"2015-10-13","recordDate":"2015-10-15","paymentDate":"2015-11-16","value":0.51,"currency":"USD"},{"executeDate":"2016-01-13","recordDate":"2016-01-15","paymentDate":"2016-02-16","value":0.57,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-05-16","value":0.57,"currency":"USD"},{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-08-15","value":0.57,"currency":"USD"},{"executeDate":"2016-10-12","recordDate":"2016-10-14","paymentDate":"2016-11-15","value":0.57,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABBV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2258,"buy":0.4516,"hold":0.3226,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4516,"analysts":31,"updateTime":1754971200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABBV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABBV","date":"2025-08-22","current":98.350772,"percent":1,"low":18.777893,"twenty":22.399948,"median":31.770473,"eighty":62.5006,"high":98.350772,"avg":40.521761,"sd":20.364981,"marketCap":370093954003},"quantilePoints":[{"date":"2020-08-28","current":23.888795,"twenty":20.471609,"median":24.278909,"eighty":35.971396,"marketCap":166194346775},{"date":"2020-09-04","current":23.305337,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":162135230310},{"date":"2020-09-11","current":22.754857,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":158305542166},{"date":"2020-09-18","current":22.858865,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":159029123797},{"date":"2020-09-25","current":21.874597,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152181570802},{"date":"2020-10-02","current":21.846692,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":151987439145},{"date":"2020-10-09","current":22.247503,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":154775875674},{"date":"2020-10-16","current":21.884744,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152252164132},{"date":"2020-10-23","current":21.395147,"twenty":20.472699,"median":24.256547,"eighty":35.971396,"marketCap":148846035967},{"date":"2020-10-30","current":20.347827,"twenty":20.466853,"median":24.256547,"eighty":35.971396,"marketCap":150187309234},{"date":"2020-11-06","current":22.208949,"twenty":20.466853,"median":24.228983,"eighty":35.971396,"marketCap":163924253750},{"date":"2020-11-13","current":23.689546,"twenty":20.466853,"median":24.164263,"eighty":35.971396,"marketCap":174852537333},{"date":"2020-11-20","current":24.120091,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":178030390395},{"date":"2020-11-27","current":25.088817,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":185180559783},{"date":"2020-12-04","current":25.660485,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":189400042459},{"date":"2020-12-11","current":25.435645,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":187740496971},{"date":"2020-12-18","current":24.983573,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":184403751257},{"date":"2020-12-24","current":24.698935,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":182302837288},{"date":"2020-12-31","current":25.62939,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189170530849},{"date":"2021-01-08","current":25.658093,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189382387720},{"date":"2021-01-15","current":26.435466,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195120177969},{"date":"2021-01-22","current":26.516792,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195720439103},{"date":"2021-01-29","current":24.512365,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":180925767629},{"date":"2021-02-05","current":41.585784,"twenty":20.466853,"median":24.227431,"eighty":36.040882,"marketCap":191959979647},{"date":"2021-02-12","current":39.944995,"twenty":20.466853,"median":24.256547,"eighty":36.146771,"marketCap":184386096518},{"date":"2021-02-19","current":40.172278,"twenty":20.466853,"median":24.287457,"eighty":36.294777,"marketCap":185435236266},{"date":"2021-02-26","current":41.216658,"twenty":20.466853,"median":24.337426,"eighty":36.404226,"marketCap":190256093280},{"date":"2021-03-05","current":40.818799,"twenty":20.466178,"median":24.378392,"eighty":36.750131,"marketCap":188419576323},{"date":"2021-03-12","current":41.400285,"twenty":20.466178,"median":24.379616,"eighty":36.795798,"marketCap":191103716491},{"date":"2021-03-19","current":39.564013,"twenty":20.466178,"median":24.409847,"eighty":36.844037,"marketCap":182627484379},{"date":"2021-03-26","current":40.519116,"twenty":20.466853,"median":24.44121,"eighty":37.032995,"marketCap":187036238813},{"date":"2021-04-01","current":41.490229,"twenty":20.466853,"median":24.44121,"eighty":37.085025,"marketCap":191518896358},{"date":"2021-04-09","current":41.115547,"twenty":20.466178,"median":24.440608,"eighty":37.16205,"marketCap":189789367069},{"date":"2021-04-16","current":41.257009,"twenty":20.466178,"median":24.440608,"eighty":37.259163,"marketCap":190442352617},{"date":"2021-04-23","current":42.583687,"twenty":20.466178,"median":24.440608,"eighty":37.311305,"marketCap":196566298160},{"date":"2021-04-30","current":38.142678,"twenty":20.466178,"median":24.440608,"eighty":37.626818,"marketCap":196778077257},{"date":"2021-05-07","current":39.62788,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":204440235392},{"date":"2021-05-14","current":39.860684,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205641266580},{"date":"2021-05-21","current":39.754553,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205093737656},{"date":"2021-05-28","current":38.754869,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199936368435},{"date":"2021-06-04","current":38.467289,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":198452741672},{"date":"2021-06-11","current":39.514903,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203857382021},{"date":"2021-06-18","current":38.72748,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199795070648},{"date":"2021-06-25","current":38.67955,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199547799521},{"date":"2021-07-02","current":39.429313,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203415826437},{"date":"2021-07-09","current":39.912037,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205906199930},{"date":"2021-07-16","current":40.227006,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":207531124480},{"date":"2021-07-23","current":40.463233,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":208749817891},{"date":"2021-07-30","current":30.828704,"twenty":20.466178,"median":24.440608,"eighty":37.719322,"marketCap":205411657676},{"date":"2021-08-06","current":30.354681,"twenty":20.466178,"median":24.440608,"eighty":37.391572,"marketCap":202253239637},{"date":"2021-08-13","current":30.893082,"twenty":20.466178,"median":24.440608,"eighty":37.288928,"marketCap":205840605967},{"date":"2021-08-20","current":31.513702,"twenty":20.466178,"median":24.440608,"eighty":37.212873,"marketCap":209975796712},{"date":"2021-08-27","current":31.715271,"twenty":20.466178,"median":24.440608,"eighty":37.144732,"marketCap":211318850116},{"date":"2021-09-03","current":29.604102,"twenty":20.466178,"median":24.440608,"eighty":37.055599,"marketCap":197252132881},{"date":"2021-09-10","current":28.293905,"twenty":20.466178,"median":24.440608,"eighty":36.9642,"marketCap":188522285753},{"date":"2021-09-17","current":28.572388,"twenty":20.466178,"median":24.440608,"eighty":36.820278,"marketCap":190377820062},{"date":"2021-09-24","current":28.397341,"twenty":20.466178,"median":24.440608,"eighty":36.787789,"marketCap":189211484211},{"date":"2021-10-01","current":28.93309,"twenty":20.466178,"median":24.440608,"eighty":36.538082,"marketCap":192781178785},{"date":"2021-10-08","current":29.487404,"twenty":20.466178,"median":24.440608,"eighty":36.364331,"marketCap":196474575647},{"date":"2021-10-15","current":28.996743,"twenty":20.466178,"median":24.440608,"eighty":36.272778,"marketCap":193205300913},{"date":"2021-10-22","current":28.946351,"twenty":20.466178,"median":24.440608,"eighty":36.089393,"marketCap":192869537562},{"date":"2021-10-29","current":26.897003,"twenty":20.466178,"median":24.440608,"eighty":35.979473,"marketCap":202642018254},{"date":"2021-11-05","current":27.496713,"twenty":20.466178,"median":24.440608,"eighty":35.893834,"marketCap":207160232888},{"date":"2021-11-12","current":27.447435,"twenty":20.466178,"median":24.440608,"eighty":35.826686,"marketCap":206788977991},{"date":"2021-11-19","current":27.276138,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205498425251},{"date":"2021-11-26","current":27.339495,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205975752977},{"date":"2021-12-03","current":27.888584,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":210112593265},{"date":"2021-12-10","current":29.441991,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":221815961943},{"date":"2021-12-17","current":30.394685,"twenty":20.466178,"median":24.440608,"eighty":35.716411,"marketCap":228993556631},{"date":"2021-12-23","current":31.230052,"twenty":20.466178,"median":24.440608,"eighty":35.617966,"marketCap":235287211086},{"date":"2021-12-31","current":31.772102,"twenty":20.466178,"median":24.440608,"eighty":35.49234,"marketCap":239371014961},{"date":"2022-01-07","current":31.650082,"twenty":20.466853,"median":24.44121,"eighty":35.38963,"marketCap":238451717119},{"date":"2022-01-14","current":31.882389,"twenty":20.466853,"median":24.44121,"eighty":35.300366,"marketCap":240201918779},{"date":"2022-01-21","current":30.969586,"twenty":20.466853,"median":24.44121,"eighty":35.215099,"marketCap":233324863770},{"date":"2022-01-28","current":32.363429,"twenty":20.466853,"median":24.44121,"eighty":35.13817,"marketCap":243826073732},{"date":"2022-02-04","current":21.543267,"twenty":20.466853,"median":24.379004,"eighty":35.104764,"marketCap":248652387402},{"date":"2022-02-11","current":21.751577,"twenty":20.466853,"median":24.314673,"eighty":35.095534,"marketCap":251056704834},{"date":"2022-02-18","current":22.071878,"twenty":20.466853,"median":24.256547,"eighty":34.992103,"marketCap":254753613990},{"date":"2022-02-25","current":22.916258,"twenty":20.466853,"median":24.228983,"eighty":34.873074,"marketCap":264499447588},{"date":"2022-03-04","current":23.072568,"twenty":20.466853,"median":24.117673,"eighty":34.437795,"marketCap":266303576494},{"date":"2022-03-11","current":22.8427,"twenty":20.466853,"median":24.068013,"eighty":34.07367,"marketCap":263650445750},{"date":"2022-03-18","current":24.396605,"twenty":20.466853,"median":24.030352,"eighty":33.659591,"marketCap":281585609576},{"date":"2022-03-25","current":24.688507,"twenty":20.466853,"median":24.030352,"eighty":33.444136,"marketCap":284954746788},{"date":"2022-04-01","current":24.895099,"twenty":20.466853,"median":24.030352,"eighty":32.161158,"marketCap":287339231436},{"date":"2022-04-08","current":26.774321,"twenty":20.466853,"median":24.030352,"eighty":32.010235,"marketCap":309029210303},{"date":"2022-04-14","current":24.838477,"twenty":20.466853,"median":24.030352,"eighty":31.911234,"marketCap":286685706014},{"date":"2022-04-22","current":23.71829,"twenty":20.466853,"median":23.990825,"eighty":31.773041,"marketCap":273756500370},{"date":"2022-04-29","current":20.789481,"twenty":20.466853,"median":23.93685,"eighty":31.728457,"marketCap":259431929637},{"date":"2022-05-06","current":21.641753,"twenty":20.471609,"median":23.919764,"eighty":31.65145,"marketCap":270067433984},{"date":"2022-05-13","current":21.736629,"twenty":20.49488,"median":23.919764,"eighty":31.65145,"marketCap":271251397740},{"date":"2022-05-20","current":21.384029,"twenty":20.584423,"median":23.919764,"eighty":31.65145,"marketCap":266851293633},{"date":"2022-05-27","current":21.241006,"twenty":20.63248,"median":23.919764,"eighty":31.65145,"marketCap":265066512450},{"date":"2022-06-03","current":20.840259,"twenty":20.656606,"median":23.919764,"eighty":31.65145,"marketCap":260065590915},{"date":"2022-06-10","current":20.27808,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":253050163885},{"date":"2022-06-17","current":19.581375,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":244355982277},{"date":"2022-06-24","current":21.572366,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":269201550044},{"date":"2022-07-01","current":21.779111,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271781530765},{"date":"2022-07-08","current":21.644585,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":270102776186},{"date":"2022-07-15","current":21.753622,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271463450950},{"date":"2022-07-22","current":21.024348,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":262362834023},{"date":"2022-07-29","current":20.067893,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":253597968011},{"date":"2022-08-05","current":19.313764,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":244068040169},{"date":"2022-08-12","current":19.951773,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":252130560187},{"date":"2022-08-19","current":19.846838,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":250804487815},{"date":"2022-08-26","current":19.077309,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":241079957093},{"date":"2022-09-02","current":19.067515,"twenty":20.656456,"median":23.920291,"eighty":31.652818,"marketCap":240956190338},{"date":"2022-09-09","current":19.786675,"twenty":20.595877,"median":23.920291,"eighty":31.652818,"marketCap":250044206322},{"date":"2022-09-16","current":20.156048,"twenty":20.476993,"median":23.900397,"eighty":31.652818,"marketCap":254711981069},{"date":"2022-09-23","current":20.016134,"twenty":20.455391,"median":23.887831,"eighty":31.652818,"marketCap":252943884574},{"date":"2022-09-30","current":18.777893,"twenty":20.415192,"median":23.86089,"eighty":31.652818,"marketCap":237296230593},{"date":"2022-10-07","current":19.414503,"twenty":20.32543,"median":23.832384,"eighty":31.652818,"marketCap":245341069646},{"date":"2022-10-14","current":19.999344,"twenty":20.291044,"median":23.721085,"eighty":31.652818,"marketCap":252731712995},{"date":"2022-10-21","current":20.575791,"twenty":20.264429,"median":23.655412,"eighty":31.652818,"marketCap":260016270554},{"date":"2022-10-28","current":19.464223,"twenty":20.259089,"median":23.613004,"eighty":31.652818,"marketCap":260956835438},{"date":"2022-11-04","current":19.156983,"twenty":20.231602,"median":23.54736,"eighty":31.652818,"marketCap":256837673955},{"date":"2022-11-11","current":19.800472,"twenty":20.186853,"median":23.498486,"eighty":31.652818,"marketCap":265464930624},{"date":"2022-11-18","current":20.436049,"twenty":20.140891,"median":23.460701,"eighty":31.652818,"marketCap":273986114465},{"date":"2022-11-25","current":21.047891,"twenty":20.140891,"median":23.4195,"eighty":31.652818,"marketCap":282189079823},{"date":"2022-12-02","current":21.580616,"twenty":20.140891,"median":23.312456,"eighty":31.652818,"marketCap":289331316901},{"date":"2022-12-09","current":21.501498,"twenty":20.140891,"median":23.254346,"eighty":31.652818,"marketCap":288270588622},{"date":"2022-12-16","current":21.161293,"twenty":20.140891,"median":23.143047,"eighty":31.652818,"marketCap":283709457023},{"date":"2022-12-23","current":21.506773,"twenty":20.140891,"median":23.049581,"eighty":31.652818,"marketCap":288341303841},{"date":"2022-12-30","current":21.310298,"twenty":20.140891,"median":22.955262,"eighty":31.652818,"marketCap":285707161948},{"date":"2023-01-06","current":21.961698,"twenty":20.140891,"median":22.924243,"eighty":31.652818,"marketCap":294440491445},{"date":"2023-01-13","current":20.254079,"twenty":20.128039,"median":22.88677,"eighty":31.652818,"marketCap":271546439424},{"date":"2023-01-20","current":19.725311,"twenty":20.087275,"median":22.858865,"eighty":31.652818,"marketCap":264457238759},{"date":"2023-01-27","current":19.288846,"twenty":20.063902,"median":22.808986,"eighty":31.58391,"marketCap":258605554420},{"date":"2023-02-03","current":19.146434,"twenty":20.02201,"median":22.751914,"eighty":31.360556,"marketCap":256696243518},{"date":"2023-02-10","current":22.710901,"twenty":20.005604,"median":22.710901,"eighty":31.151136,"marketCap":268806224703},{"date":"2023-02-17","current":22.619796,"twenty":20.005604,"median":22.66283,"eighty":30.904912,"marketCap":267727909612},{"date":"2023-02-24","current":22.829087,"twenty":20.005604,"median":22.645014,"eighty":30.684887,"marketCap":270205069571},{"date":"2023-03-03","current":23.329888,"twenty":20.005604,"median":22.645014,"eighty":30.504652,"marketCap":276132559474},{"date":"2023-03-10","current":22.380607,"twenty":20.005604,"median":22.619796,"eighty":30.197139,"marketCap":264896869658},{"date":"2023-03-17","current":23.054821,"twenty":20.005604,"median":22.619796,"eighty":29.636874,"marketCap":272876863527},{"date":"2023-03-24","current":23.552694,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":278769685181},{"date":"2023-03-31","current":23.75391,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":281151276594},{"date":"2023-04-06","current":23.96705,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":283673999349},{"date":"2023-04-14","current":24.248752,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":287008227327},{"date":"2023-04-21","current":24.107156,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":285332292629},{"date":"2023-04-28","current":34.624626,"twenty":20.005604,"median":22.619796,"eighty":29.534083,"marketCap":262627787830},{"date":"2023-05-05","current":34.273426,"twenty":20.003999,"median":22.619394,"eighty":29.832035,"marketCap":259963933732},{"date":"2023-05-12","current":34.097195,"twenty":20.003999,"median":22.619394,"eighty":30.429562,"marketCap":258627224191},{"date":"2023-05-19","current":33.364497,"twenty":20.003999,"median":22.619394,"eighty":30.595519,"marketCap":253069711699},{"date":"2023-05-26","current":32.243353,"twenty":20.003999,"median":22.619394,"eighty":30.868682,"marketCap":244565835441},{"date":"2023-06-02","current":31.038473,"twenty":20.003999,"median":22.619394,"eighty":31.001499,"marketCap":235426814899},{"date":"2023-06-09","current":32.015403,"twenty":20.003999,"median":22.619394,"eighty":31.230052,"marketCap":242836831555},{"date":"2023-06-16","current":31.608349,"twenty":20.003999,"median":22.619394,"eighty":31.499834,"marketCap":239749324615},{"date":"2023-06-23","current":31.961904,"twenty":20.002393,"median":22.619796,"eighty":31.594638,"marketCap":242431044928},{"date":"2023-06-30","current":30.989626,"twenty":20.000788,"median":22.674437,"eighty":31.615327,"marketCap":235056314066},{"date":"2023-07-07","current":31.924688,"twenty":20.000788,"median":22.719209,"eighty":31.656922,"marketCap":242148758580},{"date":"2023-07-14","current":31.073363,"twenty":20.000788,"median":22.725831,"eighty":31.656922,"marketCap":235691458351},{"date":"2023-07-21","current":33.073744,"twenty":20.000788,"median":22.747044,"eighty":31.715785,"marketCap":250864349599},{"date":"2023-07-28","current":30.237711,"twenty":20.000788,"median":22.794968,"eighty":31.73628,"marketCap":262614518868},{"date":"2023-08-04","current":30.278339,"twenty":20.000788,"median":22.840032,"eighty":31.73628,"marketCap":262967376804},{"date":"2023-08-11","current":30.777049,"twenty":20.000788,"median":22.876107,"eighty":31.73628,"marketCap":267298669219},{"date":"2023-08-18","current":30.488463,"twenty":20.000788,"median":22.903399,"eighty":31.73628,"marketCap":264792302933},{"date":"2023-08-25","current":29.799516,"twenty":20.000499,"median":22.912503,"eighty":31.736322,"marketCap":258808794688},{"date":"2023-09-01","current":29.866581,"twenty":20.000499,"median":22.961834,"eighty":31.736322,"marketCap":259391260092},{"date":"2023-09-08","current":30.262879,"twenty":20.000499,"median":23.049581,"eighty":31.736322,"marketCap":262833101118},{"date":"2023-09-15","current":31.224153,"twenty":20.000499,"median":23.07874,"eighty":31.736322,"marketCap":271181771915},{"date":"2023-09-22","current":31.181475,"twenty":20.000499,"median":23.211789,"eighty":31.736322,"marketCap":270811112112},{"date":"2023-09-29","current":30.941665,"twenty":20.000499,"median":23.269501,"eighty":31.736322,"marketCap":268728357030},{"date":"2023-10-06","current":29.966164,"twenty":20.000499,"median":23.340513,"eighty":31.736322,"marketCap":260256132966},{"date":"2023-10-13","current":30.138909,"twenty":20.000499,"median":23.434713,"eighty":31.736322,"marketCap":261756422644},{"date":"2023-10-20","current":29.573931,"twenty":20.000499,"median":23.482911,"eighty":31.736322,"marketCap":256849592873},{"date":"2023-10-27","current":29.508898,"twenty":20.025934,"median":23.532342,"eighty":31.736447,"marketCap":256284777936},{"date":"2023-11-03","current":38.818021,"twenty":20.064885,"median":23.574586,"eighty":31.77145,"marketCap":252860587376},{"date":"2023-11-10","current":37.413998,"twenty":20.093125,"median":23.635568,"eighty":31.873171,"marketCap":243714785594},{"date":"2023-11-17","current":37.479047,"twenty":20.153246,"median":23.719687,"eighty":31.93114,"marketCap":244138514575},{"date":"2023-11-24","current":37.584752,"twenty":20.203428,"median":23.764425,"eighty":31.993004,"marketCap":244827074170},{"date":"2023-12-01","current":38.593011,"twenty":20.233906,"median":23.836611,"eighty":32.031772,"marketCap":251394873376},{"date":"2023-12-08","current":40.105399,"twenty":20.254383,"median":23.887831,"eighty":32.111411,"marketCap":261246572185},{"date":"2023-12-15","current":41.978268,"twenty":20.281644,"median":23.913883,"eighty":32.197857,"marketCap":273446435764},{"date":"2023-12-22","current":41.357592,"twenty":20.317955,"median":23.921773,"eighty":32.898827,"marketCap":269403355070},{"date":"2023-12-29","current":41.943033,"twenty":20.358981,"median":23.957161,"eighty":33.273317,"marketCap":273216915899},{"date":"2024-01-05","current":43.761694,"twenty":20.423435,"median":24.01817,"eighty":33.364497,"marketCap":285063671994},{"date":"2024-01-12","current":44.3905,"twenty":20.460384,"median":24.053498,"eighty":34.097195,"marketCap":289159718811},{"date":"2024-01-19","current":44.260402,"twenty":20.478089,"median":24.095977,"eighty":34.278187,"marketCap":288312260849},{"date":"2024-01-26","current":44.756401,"twenty":20.553124,"median":24.120091,"eighty":35.147938,"marketCap":291543194329},{"date":"2024-02-02","current":45.423153,"twenty":20.593863,"median":24.228723,"eighty":37.173308,"marketCap":295886416385},{"date":"2024-02-09","current":63.458418,"twenty":20.593863,"median":24.25849,"eighty":37.413998,"marketCap":308598285816},{"date":"2024-02-16","current":64.111917,"twenty":20.593863,"median":24.303452,"eighty":37.487178,"marketCap":311776253174},{"date":"2024-02-23","current":64.204023,"twenty":20.593863,"median":24.387036,"eighty":37.584752,"marketCap":312224166203},{"date":"2024-03-01","current":63.94975,"twenty":20.619083,"median":24.46262,"eighty":37.685479,"marketCap":310987634851},{"date":"2024-03-08","current":65.59163,"twenty":20.675521,"median":24.520094,"eighty":38.122626,"marketCap":318972094434},{"date":"2024-03-15","current":65.820476,"twenty":20.718499,"median":24.641098,"eighty":38.309656,"marketCap":320084972650},{"date":"2024-03-22","current":64.628797,"twenty":20.718499,"median":24.761685,"eighty":38.446792,"marketCap":314289839482},{"date":"2024-03-28","current":65.666499,"twenty":20.727926,"median":24.813227,"eighty":38.489808,"marketCap":319336183384},{"date":"2024-04-05","current":61.13338,"twenty":20.724828,"median":24.923775,"eighty":38.67955,"marketCap":297291628445},{"date":"2024-04-12","current":60.99502,"twenty":20.724828,"median":25.009872,"eighty":38.740116,"marketCap":296618782592},{"date":"2024-04-19","current":59.953677,"twenty":20.749631,"median":25.058842,"eighty":38.963687,"marketCap":291554732220},{"date":"2024-04-26","current":60.911276,"twenty":20.790512,"median":25.196454,"eighty":39.089597,"marketCap":296211533786},{"date":"2024-05-03","current":47.511721,"twenty":20.790512,"median":25.385187,"eighty":39.260827,"marketCap":284737741336},{"date":"2024-05-10","current":47.262672,"twenty":20.790512,"median":25.595836,"eighty":39.281414,"marketCap":283245192072},{"date":"2024-05-17","current":48.426559,"twenty":20.790512,"median":25.708617,"eighty":39.35331,"marketCap":290220369807},{"date":"2024-05-24","current":46.63211,"twenty":20.790512,"median":25.889623,"eighty":39.401951,"marketCap":279466235021},{"date":"2024-05-31","current":46.057533,"twenty":20.790512,"median":26.008509,"eighty":39.514903,"marketCap":276022792848},{"date":"2024-06-07","current":49.670004,"twenty":20.790512,"median":26.275101,"eighty":39.598251,"marketCap":297672331843},{"date":"2024-06-14","current":49.077747,"twenty":20.789481,"median":26.435348,"eighty":39.621033,"marketCap":294122937603},{"date":"2024-06-21","current":50.718976,"twenty":20.787742,"median":26.51701,"eighty":39.664583,"marketCap":303958821143},{"date":"2024-06-28","current":49.793759,"twenty":20.844337,"median":26.686669,"eighty":39.682345,"marketCap":298413996311},{"date":"2024-07-05","current":48.276285,"twenty":20.891877,"median":26.774321,"eighty":39.727716,"marketCap":289319777239},{"date":"2024-07-12","current":50.064841,"twenty":20.961971,"median":26.897003,"eighty":39.809021,"marketCap":300038594669},{"date":"2024-07-15","current":50.173864,"twenty":20.965963,"median":26.897106,"eighty":39.8291,"marketCap":300691965748},{"date":"2024-08-02","current":62.746353,"twenty":21.041401,"median":27.192211,"eighty":39.858924,"marketCap":335002776733},{"date":"2024-08-09","current":62.991543,"twenty":21.041401,"median":27.341842,"eighty":39.929328,"marketCap":336311849048},{"date":"2024-08-16","current":63.984057,"twenty":21.041401,"median":27.426316,"eighty":40.031862,"marketCap":341610880283},{"date":"2024-08-23","current":64.966646,"twenty":21.041401,"median":27.473717,"eighty":40.11022,"marketCap":346856921205},{"date":"2024-08-30","current":64.572949,"twenty":21.041401,"median":27.670608,"eighty":40.180948,"marketCap":344754972149},{"date":"2024-09-06","current":63.805405,"twenty":21.041401,"median":27.905087,"eighty":40.225134,"marketCap":340657054660},{"date":"2024-09-13","current":64.189177,"twenty":21.041401,"median":28.220968,"eighty":40.278795,"marketCap":342706013404},{"date":"2024-09-20","current":64.056841,"twenty":21.041401,"median":28.434472,"eighty":40.317815,"marketCap":341999475906},{"date":"2024-09-27","current":63.4878,"twenty":21.041401,"median":28.495473,"eighty":40.397704,"marketCap":338961364665},{"date":"2024-10-04","current":64.662275,"twenty":21.041401,"median":28.571062,"eighty":40.473352,"marketCap":345231884960},{"date":"2024-10-11","current":64.298353,"twenty":21.041401,"median":28.637367,"eighty":40.552864,"marketCap":343288906840},{"date":"2024-10-18","current":62.38611,"twenty":21.041401,"median":28.78987,"eighty":40.58204,"marketCap":333079439994},{"date":"2024-10-25","current":62.743415,"twenty":21.041401,"median":28.876067,"eighty":40.639084,"marketCap":334987091239},{"date":"2024-10-31","current":69.488142,"twenty":21.041401,"median":28.970221,"eighty":40.689185,"marketCap":355918264617},{"date":"2024-11-08","current":69.17792,"twenty":21.038157,"median":28.994091,"eighty":40.821941,"marketCap":354329306164},{"date":"2024-11-15","current":58.524017,"twenty":21.038157,"median":28.994091,"eighty":40.889808,"marketCap":299760012990},{"date":"2024-11-22","current":59.248537,"twenty":21.038157,"median":28.994091,"eighty":40.998263,"marketCap":303471007668},{"date":"2024-11-29","current":63.112647,"twenty":21.038157,"median":28.994091,"eighty":41.176214,"marketCap":323262979286},{"date":"2024-12-06","current":60.780381,"twenty":21.038157,"median":28.994091,"eighty":41.341004,"marketCap":311317110702},{"date":"2024-12-13","current":59.752252,"twenty":21.038157,"median":28.994091,"eighty":41.443897,"marketCap":306051032540},{"date":"2024-12-20","current":59.176085,"twenty":21.038157,"median":28.994091,"eighty":41.561559,"marketCap":303099908200},{"date":"2024-12-27","current":61.825761,"twenty":21.038157,"median":28.994091,"eighty":41.663666,"marketCap":316671545881},{"date":"2025-01-03","current":61.908563,"twenty":21.038157,"median":28.994091,"eighty":41.928939,"marketCap":317095659559},{"date":"2025-01-10","current":61.584254,"twenty":21.034912,"median":28.970221,"eighty":42.159599,"marketCap":315434547655},{"date":"2025-01-17","current":59.928207,"twenty":21.034912,"median":28.970221,"eighty":42.586745,"marketCap":306952274105},{"date":"2025-01-24","current":58.882827,"twenty":21.034912,"median":28.970221,"eighty":43.455963,"marketCap":301597838926},{"date":"2025-01-31","current":60.600976,"twenty":21.034912,"median":28.970221,"eighty":43.940578,"marketCap":310398197734},{"date":"2025-02-07","current":79.71133,"twenty":21.034912,"median":28.970221,"eighty":44.418688,"marketCap":341005068129},{"date":"2025-02-14","current":79.909606,"twenty":21.103138,"median":29.109583,"eighty":44.684847,"marketCap":341853295484},{"date":"2025-02-21","current":82.894924,"twenty":21.140099,"median":29.423589,"eighty":45.284381,"marketCap":354624484075},{"date":"2025-02-28","current":84.603332,"twenty":21.18493,"median":29.598162,"eighty":46.234326,"marketCap":361933053192},{"date":"2025-03-07","current":86.967867,"twenty":21.272159,"median":29.776497,"eighty":47.262672,"marketCap":372048536534},{"date":"2025-03-14","current":87.297994,"twenty":21.312935,"median":29.921453,"eighty":47.521968,"marketCap":373460820421},{"date":"2025-03-21","current":87.467185,"twenty":21.372316,"median":30.010192,"eighty":47.89618,"marketCap":374184615913},{"date":"2025-03-28","current":83.825918,"twenty":21.389415,"median":30.126715,"eighty":48.261552,"marketCap":358607276516},{"date":"2025-04-04","current":83.379331,"twenty":21.435567,"median":30.174737,"eighty":48.747733,"marketCap":356696779975},{"date":"2025-04-11","current":72.032729,"twenty":21.494114,"median":30.270609,"eighty":49.07539,"marketCap":308156016027},{"date":"2025-04-17","current":70.990694,"twenty":21.518555,"median":30.298444,"eighty":49.644664,"marketCap":303698190767},{"date":"2025-04-25","current":74.584061,"twenty":21.543267,"median":30.350267,"eighty":50.064841,"marketCap":319070612002},{"date":"2025-05-02","current":81.529025,"twenty":21.580616,"median":30.452813,"eighty":50.539236,"marketCap":342014260268},{"date":"2025-05-09","current":78.256732,"twenty":21.593607,"median":30.521771,"eighty":57.878848,"marketCap":328286988831},{"date":"2025-05-16","current":76.50062,"twenty":21.644585,"median":30.640885,"eighty":58.865001,"marketCap":320920101945},{"date":"2025-05-23","current":76.862743,"twenty":21.736629,"median":30.777049,"eighty":59.176085,"marketCap":322439208548},{"date":"2025-05-30","current":78.15965,"twenty":21.779111,"median":30.832081,"eighty":59.248537,"marketCap":327879729871},{"date":"2025-06-06","current":78.938635,"twenty":21.810057,"median":30.927439,"eighty":59.814353,"marketCap":331147575471},{"date":"2025-06-13","current":81.022949,"twenty":21.848499,"median":30.989626,"eighty":60.311167,"marketCap":339891270455},{"date":"2025-06-20","current":78.10491,"twenty":21.900143,"median":31.090637,"eighty":60.568545,"marketCap":327650097478},{"date":"2025-06-27","current":78.652305,"twenty":22.008742,"median":31.217015,"eighty":60.781761,"marketCap":329946421413},{"date":"2025-07-03","current":79.700778,"twenty":22.084524,"median":31.253853,"eighty":60.912698,"marketCap":334344764950},{"date":"2025-07-11","current":82.109318,"twenty":22.16947,"median":31.346372,"eighty":61.035688,"marketCap":344448590265},{"date":"2025-07-18","current":80.593454,"twenty":22.241922,"median":31.40431,"eighty":61.154008,"marketCap":338089539367},{"date":"2025-07-25","current":80.353442,"twenty":22.32887,"median":31.515668,"eighty":61.552707,"marketCap":337082689642},{"date":"2025-08-01","current":88.728541,"twenty":22.399948,"median":31.611838,"eighty":61.840209,"marketCap":333885500163},{"date":"2025-08-08","current":93.355773,"twenty":22.399948,"median":31.701352,"eighty":62.035318,"marketCap":351297774191},{"date":"2025-08-15","current":96.088,"twenty":22.399948,"median":31.736384,"eighty":62.161632,"marketCap":361579143224},{"date":"2025-08-22","current":98.350772,"twenty":22.399948,"median":31.770473,"eighty":62.5006,"marketCap":370093954003}],"updateTime":1756121044217},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABBV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562695172","title":"AbbVie’s IMGN151 Study: A New Hope for Recurrent Gynecological Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2562695172","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562695172?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:37","pubTimestamp":1756053440,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is currently conducting a Phase 1 clinical study titled ‘A Phase 1, Fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-imgn151-study-a-new-hope-for-recurrent-gynecological-cancers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-imgn151-study-a-new-hope-for-recurrent-gynecological-cancers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1551013425.SGD","LU0432979614.USD","LU1074936037.SGD","LU0943347566.SGD","IE00BJJMRZ35.SGD","ABBV","IE00BVYPNW00.USD","LU1037948541.HKD","SG9999011175.SGD","LU0289739699.SGD","LU1162221912.USD","IE00BDGV0183.EUR","LU0985320562.USD","LU1934455863.HKD","LU2133065610.SGD","SG9999015986.USD","LU0256863811.USD","LU1244550494.USD","BK4139","LU0211328371.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU1496350502.SGD","LU0170899867.USD","LU0882574055.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE00BGHQF631.EUR","LU0820561818.USD","LU2089283258.USD","LU2089984988.USD","LU2468319806.SGD","SG9999015945.SGD","LU1585245621.USD","SG9999015952.SGD","HOPE","LU0417517546.SGD","BK4533","LU1093756325.SGD","IE0002141913.USD","LU0256863902.USD","LU0058720904.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","LU2023251221.USD","IE00B42XCP33.USD","LU2089284900.SGD","IE0004445239.USD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2562269512","title":"AbbVie’s Promising CLL Study: A Potential Game-Changer for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2562269512","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562269512?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:37","pubTimestamp":1756053429,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is currently conducting a study titled, A Prospective, Open-Label, Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-cll-study-a-potential-game-changer-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-cll-study-a-potential-game-changer-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1551013425.SGD","LU0432979614.USD","LU1074936037.SGD","LU0943347566.SGD","IE00BJJMRZ35.SGD","ABBV","IE00BVYPNW00.USD","LU1037948541.HKD","SG9999011175.SGD","LU0289739699.SGD","LU1162221912.USD","IE00BDGV0183.EUR","LU0985320562.USD","LU1934455863.HKD","LU2133065610.SGD","SG9999015986.USD","LU0256863811.USD","LU1244550494.USD","BK4139","LU0211328371.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU1496350502.SGD","LU0170899867.USD","LU0882574055.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE00BGHQF631.EUR","LU0820561818.USD","LU2089283258.USD","LU2089984988.USD","LU2468319806.SGD","SG9999015945.SGD","LU1585245621.USD","SG9999015952.SGD","ISBC","LU0417517546.SGD","BK4533","LU1093756325.SGD","IE0002141913.USD","LU0256863902.USD","LU0058720904.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","LU2023251221.USD","IE00B42XCP33.USD","LU2089284900.SGD","IE0004445239.USD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2562269550","title":"AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2562269550","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562269550?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:36","pubTimestamp":1756053362,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study titled ‘A Phase 3, Randomized, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-phase-3-study-on-upadacitinib-for-hidradenitis-suppurativa-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-phase-3-study-on-upadacitinib-for-hidradenitis-suppurativa-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863902.USD","IE0004445239.USD","IE00B42XCP33.USD","LU0965509283.SGD","LU0882574055.USD","LU1162221912.USD","LU2468319806.SGD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","BK4533","SG9999015945.SGD","LU0211328371.USD","LU2023251221.USD","LU0058720904.USD","IE0002141913.USD","LU0170899867.USD","LU0417517546.SGD","LU0965509101.SGD","LU0985320562.USD","LU1074936037.SGD","LU1551013425.SGD","BK4139","LU1934455863.HKD","LU1093756325.SGD","LU2089284900.SGD","LU2089984988.USD","ABBV","LU1585245621.USD","LU0820561818.USD","LU0289739699.SGD","LU1037948541.HKD","SG9999011175.SGD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0738911758.USD","LU0234572021.USD","LU1244550494.USD","LU2089283258.USD","LU0943347566.SGD","LU2133065610.SGD","LU0432979614.USD","IE0002270589.USD","IE00BJT1NW94.SGD","LU1496350502.SGD","LU2112291526.USD","IE00BDGV0183.EUR","SG9999015986.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0256863811.USD"],"gpt_icon":0},{"id":"2562526930","title":"AbbVie’s Promising Rheumatoid Arthritis Study: A Potential Game-Changer?","url":"https://stock-news.laohu8.com/highlight/detail?id=2562526930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562526930?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:34","pubTimestamp":1756053256,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 2, multicenter study titled ‘A Phase 2, Multicen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-rheumatoid-arthritis-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-rheumatoid-arthritis-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1934455863.HKD","LU1093756325.SGD","LU0738911758.USD","LU0943347566.SGD","IE00B19Z3B42.SGD","BK4533","LU0417517546.SGD","LU1585245621.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B42XCP33.USD","LU0432979614.USD","LU2112291526.USD","LU2089283258.USD","LU0985320562.USD","LU0170899867.USD","LU0256863902.USD","IE00BVYPNW00.USD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1074936037.SGD","LU1551013425.SGD","IE0004445239.USD","LU0234572021.USD","LU1037948541.HKD","LU0965509283.SGD","LU1162221912.USD","LU2023251221.USD","SG9999015986.USD","IE00BDGV0183.EUR","LU2133065610.SGD","IE0002141913.USD","LU0211328371.USD","LU2089284900.SGD","LU0820561818.USD","LU0256863811.USD","LU1496350502.SGD","IE00B4R5TH58.HKD","LU0965509101.SGD","LU0058720904.USD","LU2089984988.USD","LU2468319806.SGD","SG9999015952.SGD","ABBV","IE00BGHQF631.EUR","BK4139","SG9999015945.SGD","SG9999011175.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2562546269","title":"AbbVie’s Promising Study on Targeted Therapies for Crohn’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2562546269","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562546269?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:32","pubTimestamp":1756053178,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 2a multicenter, randomized study titled ‘A Phase...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-study-on-targeted-therapies-for-crohns-disease-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-study-on-targeted-therapies-for-crohns-disease-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089283258.USD","LU0289739699.SGD","LU0882574055.USD","LU2112291526.USD","LU0820561818.USD","LU1037948541.HKD","LU0738911758.USD","SG9999011175.SGD","LU1162221912.USD","LU0417517546.SGD","LU2133065610.SGD","LU1244550494.USD","LU0058720904.USD","LU0170899867.USD","BK4139","IE00BDGV0183.EUR","IE00BVYPNW00.USD","LU1551013425.SGD","LU1496350502.SGD","SG9999015952.SGD","LU0256863902.USD","LU1093756325.SGD","LU1585245621.USD","IE0002270589.USD","SG9999015945.SGD","LU2023251221.USD","LU0965509283.SGD","LU1074936037.SGD","IE00B42XCP33.USD","IE0004445239.USD","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU1934455863.HKD","SG9999015986.USD","LU0211328371.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU0256863811.USD","LU2089284900.SGD","IE00B19Z3B42.SGD","LU0234572021.USD","BK4533","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","IE00BGHQF631.EUR","ABBV","IE00BJT1NW94.SGD","LU0432979614.USD","LU0965509101.SGD"],"gpt_icon":0},{"id":"2562519269","title":"AbbVie’s SUNRISE-UC Study: A Real-World Evaluation of Risankizumab for Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2562519269","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562519269?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:32","pubTimestamp":1756053150,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a study titled ‘SUNRISE-UC’ to evaluate the effectivenes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-sunrise-uc-study-a-real-world-evaluation-of-risankizumab-for-ulcerative-colitis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-sunrise-uc-study-a-real-world-evaluation-of-risankizumab-for-ulcerative-colitis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1934455863.HKD","LU1093756325.SGD","LU0738911758.USD","LU0943347566.SGD","IE00B19Z3B42.SGD","BK4533","LU0417517546.SGD","LU1585245621.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B42XCP33.USD","LU0432979614.USD","LU2112291526.USD","LU2089283258.USD","LU0985320562.USD","LU0170899867.USD","LU0256863902.USD","IE00BVYPNW00.USD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1074936037.SGD","LU1551013425.SGD","IE0004445239.USD","LU0234572021.USD","LU1037948541.HKD","LU0965509283.SGD","LU1162221912.USD","LU2023251221.USD","SG9999015986.USD","IE00BDGV0183.EUR","LU2133065610.SGD","IE0002141913.USD","LU0211328371.USD","LU2089284900.SGD","LU0820561818.USD","LU0256863811.USD","LU1496350502.SGD","IE00B4R5TH58.HKD","LU0965509101.SGD","LU0058720904.USD","LU2089984988.USD","LU2468319806.SGD","SG9999015952.SGD","ABBV","IE00BGHQF631.EUR","BK4139","SG9999015945.SGD","SG9999011175.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2561471870","title":"Raymond James Sticks to Their Buy Rating for AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561471870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561471870?lang=en_us&edition=fundamental","pubTime":"2025-08-22 19:55","pubTimestamp":1755863733,"startTime":"0","endTime":"0","summary":"In a report released today, Gary Nachman from Raymond James reiterated a Buy rating on AbbVie, with a price target of $236.00. The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-sticks-to-their-buy-rating-for-abbvie-abbv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-sticks-to-their-buy-rating-for-abbvie-abbv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABBV","RJF"],"gpt_icon":0},{"id":"1180820777","title":"AbbVie (ABBV.US) Rinvoq Alopecia Areata Therapy Meets Primary Endpoints in Late-Stage Trials, Plans Regulatory Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=1180820777","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180820777?lang=en_us&edition=fundamental","pubTime":"2025-08-22 14:32","pubTimestamp":1755844373,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV.US) announced Thursday that its alopecia areata treatment drug Rinvoq (upadacitinib) successfully achieved primary objectives in two pivotal late-stage clinical trials. The trials...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2347655156.SGD","BK4581","IE00B19Z3581.USD","LU2129689431.USD","LU1934455194.USD","LU2023251221.USD","LU2468319806.SGD","LU1732800096.USD","LU2237443622.USD","LU1934455277.USD","LU1929549753.HKD","LU0211327993.USD","LU1989771016.USD","SG9999003800.SGD","LU0689472784.USD","LU1244550577.SGD","LU0661504455.SGD","LU1093756168.USD","IE00BDGV0183.EUR","LU0912757837.SGD","LU2129689605.HKD","LU0545039389.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU2237443895.HKD","LU1162221912.USD","IE00B2B36J28.USD","LU0198837287.USD","LU0029864427.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU2089984988.USD","LU0114720955.EUR","LU0158827948.USD","SG9999015952.SGD","LU1023059063.AUD","BK4139","LU1551013425.SGD","LU0289739699.SGD","BK4534","IE00BVYPNV92.GBP","LU0128525929.USD","LU0985320562.USD","LU0170899867.USD","LU1291159041.SGD","IE00B3PB1722.GBP","LU0211328371.USD","SG9999015978.USD","LU0203345920.USD","LU1267930573.SGD","LU1037948541.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2112291526.USD","LU2129689514.USD","LU0234570918.USD","LU1983299246.USD","LU1061106388.HKD","BK4566","LU0432979614.USD","LU0965509283.SGD","IE0002270589.USD","LU2237443382.USD","LU1839511570.USD","BK4533","BK4588","LU0456855351.SGD","LU0965509010.AUD","LU1057294990.SGD","IE00BSNM7G36.USD","LU0820561818.USD","LU0310799852.SGD","LU2237443978.SGD","LU0882574055.USD","BK4585","IE00B4R5TH58.HKD","SG9999015945.SGD","LU1244550494.USD","LU1037948897.HKD","LU1934455863.HKD","LU0553294199.USD","LU2237443549.SGD","LU1496350502.SGD","LU1718418525.SGD","LU0234572021.USD","LU0943347566.SGD","LU1430594728.SGD","LU1732799900.SGD","IE00B42XCP33.USD","LU0965509101.SGD","SG9999001440.SGD","LU2089283258.USD","LU0861579265.USD","LU2089284900.SGD","LU0795875169.SGD","BK4550","LU0820561909.HKD","LU1244550221.USD","LU1989772840.SGD","LU0058720904.USD","LU2087621335.USD","LU1496350171.SGD","LU0310800379.SGD","LU0203347892.USD","LU2133065610.SGD","LU2237443465.HKD","LU1074936037.SGD","IE0002141913.USD","LU0122379950.USD","SG9999015986.USD","LU0949170772.SGD","IE0004445239.USD","LU0256863902.USD","LU0738911758.USD","BK4559","LU1585245621.USD","ABBV","IE00BGHQF631.EUR","IE00BVYPNW00.USD","SG9999011175.SGD","LU0965508806.USD","LU0708994859.HKD","LU0795875086.SGD","LU0320765646.SGD","LU0256863811.USD","LU1989772923.USD","LU1003077747.HKD","IE00B19Z3B42.SGD","LU1267930490.SGD"],"gpt_icon":0},{"id":"2561416041","title":"AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2561416041","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561416041?lang=en_us&edition=fundamental","pubTime":"2025-08-22 02:07","pubTimestamp":1755799637,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) recently announced positive results from pivotal studies for its drug upadacitinib, which targeted severe alopecia areata, showcasing promising therapeutic advancements. Over the last quarter, AbbVie's share price increased by 15%, coinciding with broader product announcements and a strategic dividend declaration of $1.64 per share. Despite mixed earnings reports and market fluctuations, AbbVie's advances in product development and strategic expansions may have provided support...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1585186942698","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1585186942698"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-reports-positive-phase-3-results-for-rinvoq-in-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2112291526.USD","BK4585","LU0211327993.USD","LU1585245621.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","IE00B3PB1722.GBP","ABBV","IE00BVYPNV92.GBP","LU0545039389.USD","LU0708994859.HKD","LU1093756325.SGD","LU2237443382.USD","LU0965508806.USD","LU1037948541.HKD","LU0170899867.USD","LU2129689431.USD","LU0122379950.USD","LU0882574055.USD","LU1074936037.SGD","LU0211328371.USD","LU1934455863.HKD","LU1244550577.SGD","LU1496350171.SGD","IE00B19Z3581.USD","LU0114720955.EUR","BK4534","LU0943347566.SGD","LU0965509010.AUD","LU1244550221.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0256863902.USD","LU1093756168.USD","LU0234572021.USD","LU1057294990.SGD","SG9999001440.SGD","BK4581","LU1718418525.SGD","LU0256863811.USD","LU2347655156.SGD","BK4588","IE0004445239.USD","IE00B42XCP33.USD","LU1989772923.USD","LU2237443465.HKD","LU0553294199.USD","IE00BGHQF631.EUR","LU2237443978.SGD","LU0861579265.USD"],"gpt_icon":0},{"id":"2561962864","title":"AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2561962864","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561962864?lang=en_us&edition=fundamental","pubTime":"2025-08-21 22:10","pubTimestamp":1755785400,"startTime":"0","endTime":"0","summary":"AbbVie Inc. ABBV on Thursday released topline results from the second of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib  in adult and adolescent patients with severe alopecia areata  with a mean baseline SALT score of 84.0 .Alopecia areata is an autoimmune disease causing hair loss, typically in small, round patches on the scalp or other body areas. It occurs when the immune system mistakenly attacks hair follicles.In Study 1, both doses of upadacitinib achieved the primary endpoint, with 45.2% and 55.0% of patients treated with upadacitinib 15 mg and 30 mg, respectively, reaching 80% or more scalp hair coverage  at week 24, compared to 1.5% of patients receiving placebo.Also Read: AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules. Price Action: ABBV stock is trading higher by 0.88% to $210.99 at last check Thursday.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/21/Abbvie.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/21/Abbvie.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/08/47259909/abbvies-patch-baldness-study-finds-high-hair-coverage-rates-with-investigational-drug-upadacitinib","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU0198837287.USD","LU0158827948.USD","LU0310800379.SGD","LU0965509010.AUD","LU1057294990.SGD","LU1934455277.USD","LU1074936037.SGD","LU1934455863.HKD","SG9999015945.SGD","IE00BVYPNW00.USD","LU0661504455.SGD","BK4585","IE00BDGV0183.EUR","LU1093756325.SGD","AA","LU0965508806.USD","LU1430594728.SGD","LU1983299246.USD","ABBV","LU2112291526.USD","LU1989771016.USD","LU2089283258.USD","LU0432979614.USD","LU1061106388.HKD","BK4153","LU1496350502.SGD","LU1267930490.SGD","LU2237443978.SGD","LU0545039389.USD","IE00B3PB1722.GBP","SG9999015952.SGD","LU0234570918.USD","LU1267930573.SGD","LU1551013342.USD","BK4533","LU2129689605.HKD","IE00BJJMRZ35.SGD","LU0128525929.USD","LU0689472784.USD","IE0002141913.USD","LU0417517546.SGD","LU0943347566.SGD","IE0002270589.USD","IE00BGHQF631.EUR","SG9999001440.SGD","SG9999015978.USD","LU0708994859.HKD","LU1244550221.USD","LU1037948541.HKD","LU1934455194.USD"],"gpt_icon":0},{"id":"2561495848","title":"AbbVie's Rinvoq Hits Key Endpoints in 2nd Alopecia Areata Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2561495848","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561495848?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:36","pubTimestamp":1755783360,"startTime":"0","endTime":"0","summary":"AbbVie said a second late-stage study of its blockbuster autoimmune drug Rinvoq hit its main goals in the autoimmune disease alopecia areata.AbbVie on Thursday said the Phase 3 study evaluating the safety and efficacy of Rinvoq in patients with severe forms of the disease that causes sudden hair loss met its primary endpoint of 80% or more scalp hair coverage at week 24.The North Chicago, Ill., biopharmaceutical company said the study also met key secondary endpoints of improvements in eyebrows and eyelashes, as well as the percentage of subjects with 90% or more scalp coverage and complete scalp hair coverage at week 24.AbbVie in July reported similar results from a parallel Phase 3 study.AbbVie earlier this year said it expects revenue from Rinvoq, which is already approved for use in several autoimmune diseases, to top $11 billion in 2027.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbbVie's Rinvoq Hits Key Endpoints in 2nd Alopecia Areata Phase 3 Study","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","LU1093756325.SGD","LU1732800096.USD","LU2347655156.SGD","SG9999001440.SGD","LU2112291526.USD","LU0661504455.SGD","LU2237443382.USD","LU0965509101.SGD","LU0861579265.USD","LU2237443978.SGD","LU0689472784.USD","LU1551013425.SGD","IE00B19Z3581.USD","LU1244550221.USD","ABBV","LU0553294199.USD","LU0417517546.SGD","LU0203347892.USD","LU0912757837.SGD","BK4533","LU0203345920.USD","LU1162221912.USD","LU1074936037.SGD","LU0234572021.USD","LU0310800379.SGD","LU0820561818.USD","LU1496350502.SGD","IE00B42XCP33.USD","LU0289739699.SGD","BK4559","LU1093756168.USD","LU1267930573.SGD","LU1585245621.USD","LU2129689514.USD","LU1037948897.HKD","LU2089984988.USD","LU0985320562.USD","LU0158827948.USD","LU2129689431.USD","IE00B3PB1722.GBP","LU2089283258.USD","IE0002270589.USD","LU0122379950.USD","LU0456855351.SGD","BK4588","LU1989772923.USD","LU1267930490.SGD","LU1061106388.HKD","LU0965508806.USD"],"gpt_icon":0},{"id":"2561886498","title":"AbbVie’s upadacitinib achieves endpoint in Phase 3 alopecia areata trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2561886498","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561886498?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:35","pubTimestamp":1755779727,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced “positive” topline results from the second of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-upadacitinib-achieves-endpoint-in-phase-3-alopecia-areata-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-upadacitinib-achieves-endpoint-in-phase-3-alopecia-areata-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","LU0158827948.USD","UP","AA","LU0820561818.USD","SG9999015945.SGD","IE0002141913.USD","BK4566","LU1934455277.USD","LU0795875086.SGD","SG9999015986.USD","LU0820561909.HKD","ABBV","LU1934455863.HKD","LU0122379950.USD","LU0545039389.USD","LU0912757837.SGD","LU1718418525.SGD","LU0943347566.SGD","LU1003077747.HKD","LU0456855351.SGD","LU0256863902.USD","LU0320765646.SGD","LU0689472784.USD","LU1093756168.USD","LU0738911758.USD","LU1244550494.USD","LU1093756325.SGD","LU1934455194.USD","LU2237443382.USD","LU0882574055.USD","LU1023059063.AUD","LU0417517546.SGD","BK4588","BK4581","IE0004445239.USD","LU0661504455.SGD","LU0965509010.AUD","IE00BJJMRZ35.SGD","LU1989772923.USD","IE0009355771.USD","LU1732799900.SGD","LU0949170772.SGD","LU1037948897.HKD","LU1244550577.SGD","LU2237443622.USD","LU0128525929.USD","LU0861579265.USD","LU2129689514.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2561746012","title":"AbbVie Announces Positive Results from Phase 3 Trial of Upadacitinib for Alopecia Areata, Showing Promising Hair Regrowth Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2561746012","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561746012?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:31","pubTimestamp":1755779487,"startTime":"0","endTime":"0","summary":"AbbVie Announces Positive Results from Phase 3 Trial of Upadacitinib for Alopecia Areata, Showing Promising Hair Regrowth Outcomes. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via PR Newswire  on August 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL7HXPdk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU1037948541.HKD","LU1732800096.USD","LU1934455863.HKD","LU2089984988.USD","LU2087621335.USD","LU1291159041.SGD","IE0009355771.USD","LU2023251221.USD","LU1496350171.SGD","LU1989772840.SGD","LU1430594728.SGD","LU0256863811.USD","LU2237443382.USD","IE00BVYPNW00.USD","LU2468319806.SGD","BK4534","LU1267930490.SGD","LU0456855351.SGD","LU0234570918.USD","LU0943347566.SGD","LU1244550221.USD","SG9999015986.USD","LU0256863902.USD","BK4139","LU0211328371.USD","LU2237443549.SGD","LU0861579265.USD","LU0949170772.SGD","IE00B2B36J28.USD","LU0820561909.HKD","LU0985320562.USD","LU2237443622.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","LU1839511570.USD","ABBV","IE00B42XCP33.USD","BK4581","LU2112291526.USD","SG9999001440.SGD","LU0058720904.USD","BK4559","LU0128525929.USD","LU0158827948.USD","LU0170899867.USD","LU2129689514.USD","IE00BVYPNV92.GBP","LU0122379950.USD","LU0661504455.SGD"],"gpt_icon":0},{"id":"2561603460","title":"Abbvie Inc - Upadacitinib Achieves Primary Endpoint in Alopecia Areata Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2561603460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561603460?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA33FR4T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089284900.SGD","LU0820561909.HKD","BK4585","LU0689472784.USD","LU0211327993.USD","LU0795875169.SGD","LU1585245621.USD","SG9999015945.SGD","IE00B3PB1722.GBP","LU0203345920.USD","ABBV","BK4139","IE00BVYPNV92.GBP","LU2133065610.SGD","LU1929549753.HKD","LU1093756325.SGD","LU0456855351.SGD","LU1037948541.HKD","LU0170899867.USD","SG9999015978.USD","LU2129689431.USD","LU1074936037.SGD","LU2237443549.SGD","LU0310800379.SGD","LU0234570918.USD","LU0661504455.SGD","SG9999003800.SGD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","LU0965509010.AUD","LU1989771016.USD","LU0912757837.SGD","LU2087621335.USD","IE00B2B36J28.USD","LU0029864427.USD","LU1057294990.SGD","LU1267930490.SGD","LU2237443622.USD","LU2129689605.HKD","SG9999011175.SGD","LU1496350502.SGD","LU0949170772.SGD","LU0203347892.USD","LU1430594728.SGD","LU1162221912.USD","LU1983299246.USD","BK4533","LU1551013342.USD","IE0009355771.USD","LU0738911758.USD"],"gpt_icon":0},{"id":"2561602460","title":"Abbvie Inc - Key Secondary Endpoints Met in Upadacitinib Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2561602460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561602460?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA33FR4T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1496350502.SGD","LU0949170772.SGD","LU2087621335.USD","LU1267930490.SGD","SG9999003800.SGD","IE00B2B36J28.USD","BK4533","LU0795875169.SGD","LU0170899867.USD","LU0234570918.USD","LU1093756325.SGD","LU2089284900.SGD","SG9999011175.SGD","LU1074936037.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU2237443622.USD","SG9999015978.USD","LU0029864427.USD","IE0009355771.USD","LU1585245621.USD","LU0203347892.USD","LU1929549753.HKD","LU0912757837.SGD","LU1983299246.USD","IE00BVYPNV92.GBP","LU1989771016.USD","LU1551013342.USD","LU1162221912.USD","IE00B3PB1722.GBP","LU2129689431.USD","LU0738911758.USD","LU0661504455.SGD","LU2133065610.SGD","LU0965509010.AUD","LU1057294990.SGD","LU0203345920.USD","SG9999015945.SGD","LU1037948541.HKD","LU2129689605.HKD","LU2237443549.SGD","LU0310800379.SGD","LU0211327993.USD","LU0820561909.HKD","BK4139","LU0689472784.USD","ABBV","LU0456855351.SGD","LU1430594728.SGD","BK4585"],"gpt_icon":0},{"id":"2561460679","title":"Abbvie Inc - Upadacitinib Safety Profile Consistent With Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460679?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA33FR4T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1929549753.HKD","IE0009355771.USD","LU1074936037.SGD","LU2129689605.HKD","LU1037948541.HKD","ABBV","SG9999011175.SGD","LU0456855351.SGD","LU1430594728.SGD","SG9999003800.SGD","BK4139","BK4585","LU0310800379.SGD","LU2237443622.USD","LU1983299246.USD","LU0234570918.USD","LU0738911758.USD","LU0820561909.HKD","LU0203345920.USD","IE00B19Z3581.USD","IE00BVYPNV92.GBP","LU1989771016.USD","LU0170899867.USD","LU0661504455.SGD","LU1267930490.SGD","LU0965509010.AUD","LU2129689431.USD","LU0689472784.USD","LU2089284900.SGD","LU0912757837.SGD","LU0795875169.SGD","LU0029864427.USD","LU2133065610.SGD","LU0203347892.USD","LU1093756325.SGD","LU0211327993.USD","LU1585245621.USD","SG9999015945.SGD","IE00B2B36J28.USD","SG9999015978.USD","BK4533","LU1551013342.USD","IE00B3PB1722.GBP","LU2087621335.USD","LU1162221912.USD","LU1496350502.SGD","LU1057294990.SGD","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0949170772.SGD"],"gpt_icon":0},{"id":"2561460606","title":"Abbvie Announces Positive Topline Results From Second Phase 3 up-Aa Trial Evaluating Upadacitinib (Rinvoq®) for Alopecia Areata","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460606?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA33FR4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","LU2129689431.USD","SG9999003800.SGD","LU0211327993.USD","LU1496350502.SGD","LU1074936037.SGD","LU2133065610.SGD","LU2237443549.SGD","SG9999015978.USD","LU0029864427.USD","LU0456855351.SGD","ABBV","LU2237443622.USD","SG9999011175.SGD","BK4585","LU0949170772.SGD","LU2089284900.SGD","LU1162221912.USD","LU2129689605.HKD","LU0234570918.USD","LU0795875169.SGD","LU0203347892.USD","IE00B19Z3581.USD","LU0170899867.USD","LU0310800379.SGD","LU0965509010.AUD","BK4533","IE00B2B36J28.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU0661504455.SGD","LU1929549753.HKD","BK4139","LU1430594728.SGD","LU0738911758.USD","IE00BVYPNV92.GBP","LU1585245621.USD","SG9999015945.SGD","LU1037948541.HKD","LU0912757837.SGD","LU1093756325.SGD","IE0009355771.USD","LU1551013342.USD","LU1267930490.SGD","LU0203345920.USD","LU1989771016.USD","LU0820561909.HKD","IE00BJJMRZ35.SGD","LU0689472784.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"2561481729","title":"AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481729","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481729?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:31","pubTimestamp":1755721860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rose 1.44% to $209.15 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.04% to 44,938.31 and the S&P 500 Index  falling 0.24% to 6,395.78.The stock's rise snapped a two-day losing streak.AbbVie Inc. closed 4.35% short of its 52-week high of $218.66, which the company achieved on March 10th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 0.58% to $178.84, Pfizer Inc.  rose 0.24% to $25.38, and Amgen Inc.  rose 0.30% to $296.45.Trading volume  remained 19,789 below its 50-day average volume of 5.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"gpt_icon":0},{"id":"2561488873","title":"AbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Relief","url":"https://stock-news.laohu8.com/highlight/detail?id=2561488873","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561488873?lang=en_us&edition=fundamental","pubTime":"2025-08-21 00:16","pubTimestamp":1755706611,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study titled...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-atogepant-study-a-new-hope-for-menstrual-migraine-relief?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-atogepant-study-a-new-hope-for-menstrual-migraine-relief?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0861579265.USD","LU1839511570.USD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU0965509283.SGD","IE00BFTCPJ56.SGD","LU0661504455.SGD","HOPE","LU1496350171.SGD","IE00BVYPNV92.GBP","LU0122379950.USD","LU0114720955.EUR","LU1929549753.HKD","LU1061106388.HKD","LU0417517546.SGD","LU0708994859.HKD","LU2237443978.SGD","IE00B42XCP33.USD","LU0211327993.USD","LU0234572021.USD","BK4566","LU2112291526.USD","IE00B19Z3581.USD","LU1551013425.SGD","LU0985320562.USD","LU1267930490.SGD","LU1291159041.SGD","LU1718418525.SGD","SG9999003800.SGD","LU0545039389.USD","LU2129689605.HKD","LU2089984988.USD","ABBV","LU0882574055.USD","LU2129689431.USD","SG9999001440.SGD","LU0965509010.AUD","LU0203345920.USD","LU2468319806.SGD","LU1093756168.USD","LU1989772923.USD","BK4588","LU1934455863.HKD","LU0943347566.SGD","LU2133065610.SGD","SG9999011175.SGD","SG9999015986.USD","LU2237443895.HKD","LU0198837287.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2561488381","title":"AbbVie’s Promising Crohn’s Disease Study: A Potential Game Changer?","url":"https://stock-news.laohu8.com/highlight/detail?id=2561488381","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561488381?lang=en_us&edition=fundamental","pubTime":"2025-08-21 00:16","pubTimestamp":1755706593,"startTime":"0","endTime":"0","summary":"Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 2a multicenter, randomi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-crohns-disease-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-promising-crohns-disease-study-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","BK4566","LU2237443895.HKD","LU0912757837.SGD","LU0943347566.SGD","LU1718418525.SGD","LU0545039389.USD","LU1496350171.SGD","IE00BVYPNV92.GBP","LU1934455863.HKD","LU0114720955.EUR","LU0211327993.USD","LU1057294990.SGD","LU1929549753.HKD","SG9999011175.SGD","LU0661504455.SGD","LU2468319806.SGD","LU2129689431.USD","IE00B42XCP33.USD","LU1291159041.SGD","LU1839511570.USD","LU1989772923.USD","LU2089984988.USD","LU0882574055.USD","LU0965509010.AUD","LU2133065610.SGD","LU0122379950.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","LU0708994859.HKD","BK4588","LU0985320562.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU1093756168.USD","LU0965509283.SGD","LU2129689605.HKD","SG9999001440.SGD","LU0198837287.USD","LU0861579265.USD","LU1551013425.SGD","LU0417517546.SGD","LU2112291526.USD","LU1267930490.SGD","LU0234572021.USD","LU2237443978.SGD","ABBV","SG9999015986.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}